Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/23/2022 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 12.5k | $1.60 | $20k | | 06/23/2022 |
06/01/2022 | Werewolf Therapeutics, Inc. | HOWL | Grant | Stock Option (right to buy) | 11.6k | $3.43 | $39.8k | | 06/01/2022 |
06/16/2021 | Oncorus, Inc. | ONCR | Grant | Stock Option (right to buy) | 12.5k | $16.55 | $206.9k | | 06/16/2021 |
05/04/2021 | Werewolf Therapeutics, Inc. | HOWL | Conversion | Common Stock | 2.8M | $0.00 | $0 | See Footnote | 12/23/2020 |
05/04/2021 | Werewolf Therapeutics, Inc. | HOWL | Conversion | Series B Preferred Stock | 7.9M | $0.00 | $0 | See Footnote | 12/23/2020 |
05/04/2021 | Werewolf Therapeutics, Inc. | HOWL | Conversion | Common Stock | 915.9k | $0.00 | $0 | See Footnote | 12/23/2020 |
05/04/2021 | Werewolf Therapeutics, Inc. | HOWL | Purchase | Common Stock | 150.8k | $16.00 | $2.4M | See Footnote | 12/23/2020 |
05/04/2021 | Werewolf Therapeutics, Inc. | HOWL | Conversion | Series A Preferred Stock | 23.9M | $0.00 | $0 | See Footnote | 12/23/2020 |
04/30/2021 | TURMERIC ACQUISITION CORP. | | Other (acquisition) | Class B ordinary shares | 17.5k | $0.00 | $0 | By Turmeric Management, LLC | 04/30/2021 |
04/30/2021 | Werewolf Therapeutics, Inc. | HOWL | Grant | Stock Option (Right to Buy) | 23.2k | $16.00 | $371.2k | | 04/30/2021 |
12/23/2020 | Werewolf Therapeutics, Inc. | HOWL | Purchase | Series B Preferred Stock | 7.9M | $0.00 | $0 | See Footnote | 12/23/2020 |
10/20/2020 | TURMERIC ACQUISITION CORP. | | Other (acquisition) | Class A ordinary Shares | 415.5k | $10.00 | $4.2M | By Turmeric Management, LLC | 10/20/2020 |
10/06/2020 | Oncorus, Inc. | ONCR | Purchase | Common Stock | 151.2k | $15.00 | $2.3M | See footnote | 10/06/2020 |
10/06/2020 | Oncorus, Inc. | ONCR | Conversion | Series A-1 Preferred Stock | 1.5M | $0.00 | $0 | See footnote | 10/06/2020 |
10/06/2020 | Oncorus, Inc. | ONCR | Conversion | Series B Preferred Stock | 700.4k | $0.00 | $0 | See footnote | 10/06/2020 |
10/06/2020 | Oncorus, Inc. | ONCR | Conversion | Common Stock | 1.5M | $0.00 | $0 | See footnote | 10/06/2020 |
10/06/2020 | Oncorus, Inc. | ONCR | Conversion | Common Stock | 700.4k | $0.00 | $0 | See footnote | 10/06/2020 |
05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $20.59 | $209.3k | | 05/28/2020 |
05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 3.6k | $20.59 | $73.9k | | 05/28/2020 |
06/03/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $11.84 | $120.4k | | 06/03/2019 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 76.3k | $0.05 | $3.8k | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Common Stock | 1.5M | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Common Stock | 1.6M | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Common Stock | 417.9k | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Series A Preferred Stock | 1.5M | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Series B Preferred Stock | 1.6M | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Conversion | Series C Preferred Stock | 417.9k | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 25.4k | $0.00 | $0 | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 57.2k | $0.05 | $2.8k | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 171.6k | $0.05 | $8.4k | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Payment of Exercise | Common Stock | 1.5k | $14.00 | $21.3k | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock | 250k | $14.00 | $3.5M | See Footnote | 11/09/2018 |
02/12/2019 | Harpoon Therapeutics, Inc. | HARP | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 50.8k | $0.05 | $2.5k | See Footnote | 11/09/2018 |
02/07/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 7.7k | $14.00 | $107.2k | | 02/07/2019 |
12/19/2018 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 20.3k | $2.12 | $43.1k | | 11/09/2018 |
|